MDAM blocker of folate synthesis: Began Phase I testing in 25 patients

BioNumerik Pharmaceuticals Inc. (San Antonio, Texas) Product: MDAM blocker of folate synthesis Indication: Solid tumors Status: Began Phase I testing in 25 patients ...